You are here

  • Home
  • Archive
  • Volume 22, Issue Suppl 1
  • PKP-010 Higher than recommended doses of colistimethate sodium in patients with multi-drug resistant gram-negative bacterial infections: a benefit or an increased risk of toxicity?

Alerts

Article menu
Download PDFPDF
Pharmacokinetics and pharmacodynamics
PKP-010 Higher than recommended doses of colistimethate sodium in patients with multi-drug resistant gram-negative bacterial infections: a benefit or an increased risk of toxicity?
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address